IN THIS ISSUE

Richard Mark Kirkner
The estimates range from $13.5 trillion to $47.6 trillion. The variables include the generosity of the benefit and forecasts for reining in health care expenditures.
Thomas Reinke
But discontinuation rate is high, and Wall Street is unimpressed by sales of the new class of migraine medications.
Peter Wehrwein

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report